Demand for Global Breast Biopsy Market Size & Share to Surpass USD 1,109.35 Million by 2028, Exhibit a CAGR of 7.3% | Breast Biopsy Industry Trends, Growth, Value, Analysis & Forecast Report by Facts & Factors

0 0

[227+ Pages Report] According to a market research study published by Facts and Factors, the demand analysis of Global Breast Biopsy Market size & share revenue was valued at around USD 702.13 million in 2021 and is estimated to grow to about USD 1,109.35 million by 2028, at a CAGR of approximately 7.3% between 2022 and 2028. The key market players are listed in the report with their sales, revenues and strategies are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), Medtronic (Ireland), IZI Medical Products (US), Argon Medical (US), STERYLAB S.r.l. (Italy), Scion Medical Technologies, LLC (China), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), and others. [227+ Pages Report] According to a market research study published by Facts and Factors, the demand analysis of Global Breast Biopsy Market size & share revenue was valued at around USD 702.13 million in 2021 and is estimated to grow to about USD 1,109.35 million by 2028, at a CAGR of approximately 7.3% between 2022 and 2028. The key market players are listed in the report with their sales, revenues and strategies are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), Medtronic (Ireland), IZI Medical Products (US), Argon Medical (US), STERYLAB S.r.l. (Italy), Scion Medical Technologies, LLC (China), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), and others.

 14 total views,  2 views today

Leave A Reply

Your email address will not be published.